SCHEMBL23516094

SCHEMBL23516094

CN1C(=O)c2cccc(-n3c4cc(-c5ccncc5)ccc4c4ccc(-c5ccncc5)cc43)c2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 9/20 0.43
▸ CHEK1 O14757 3/20 0.40
▸ ROCK2 O75116 3/20 0.39
▸ CAPN1 P07384 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ BRCA1 P38398 1/20 0.36
▸ CASP7 P55210 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ DYRK3 O43781 1/20 0.36
▸ RPS6KA5 O75582 1/20 0.36
▸ RPS6KA4 O75676 1/20 0.36
▸ PRKD3 O94806 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36
▸ CDK1 P06493 1/20 0.36
▸ CSF1R P07333 1/20 0.36
▸ PRKACA P17612 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CSNK1D P48730 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23516356 0.96 MAPK14 (0.41) METAP2CHEK1ROCK2MAP4K4PRKACA
SCHEMBL23516095 0.91 ROCK2 (0.39) METAP2CHEK1ROCK2MEN1USP2
SCHEMBL23516097 0.89 MAPK14 (0.41) METAP2ROCK2MAP4K4PRKACACDK2
SCHEMBL23515966 0.88 METAP2 (0.46) METAP2CHEK1CAPN1
SCHEMBL23516515 0.85 METAP2 (0.43) METAP2CHEK1GSK3B
SCHEMBL23515988 0.84 MEN1 (0.36) MEN1USP2CASP1BRCA1CASP7
SCHEMBL23516516 0.84 PDE10A (0.37) METAP2CHEK1
SCHEMBL23515926 0.84 CHEK1 (0.41) CHEK1MEN1USP2CASP1BRCA1
SCHEMBL23516533 0.83 METAP2 (0.47) METAP2CAPN1
SCHEMBL23516004 0.83 HSPA1A (0.44) METAP2CAPN1MEN1USP2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276825-B2 Organic molecules for use in organic devices CYNORA GMBH (DE) 2022-03-15 — — US disclosed
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210184134-A1 ORGANIC MOLECULES FOR USE IN ORGANIC DEVICES CHRM1, C1S, DNMT3L METAP2 3053/4885CHEK1 2819/4885ROCK2 747/4885
US-11276825-B2 Organic molecules for use in organic devices AOX1, OR10J3, L1CAM METAP2 3608/4885CHEK1 3433/4885ROCK2 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback